BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,620.00
-70.00 (-0.81%)
At close: Apr 28, 2026
Market Cap 129.68B
Revenue (ttm) 28.49B
Net Income (ttm) 4.15B
Shares Out 15.04M
EPS (ttm) 298.00
PE Ratio 28.93
Forward PE n/a
Dividend 100.00 (1.16%)
Ex-Dividend Date Dec 29, 2025
Volume 39,822
Average Volume 62,925
Open 8,750.00
Previous Close 8,690.00
Day's Range 8,480.00 - 8,750.00
52-Week Range 7,690.00 - 26,500.00
Beta n/a
RSI 46.75
Earnings Date May 14, 2026

About BIOBIJOU

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 489460
Full Company Profile

Financial Performance

In 2025, BIOBIJOU's revenue was 28.49 billion, a decrease of -3.86% compared to the previous year's 29.63 billion. Earnings were 4.15 billion, a decrease of -42.24%.

Financial Statements

News

There is no news available yet.